Modifications of benzylphenoxy ethanamine antiestrogen molecules:: Influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity

被引:20
作者
Delarue, F [1 ]
Kedjouar, B [1 ]
Mésange, F [1 ]
Bayard, F [1 ]
Faye, JC [1 ]
Poirot, M [1 ]
机构
[1] CHU Rangueil, Inst Louis Bugnard, INSERM U397, Lab Endocrinol & Cellular Commun, F-31403 Toulouse, France
关键词
AEBS; tamoxifen; diphenylmethane; benzophenone; cytotoxicity; cell;
D O I
10.1016/S0006-2952(98)00347-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The antiestrogen binding site (AEBS) is a membranous protein complex that has been shown to be intimately linked with the antiproliferative and antiretroviral effects of certain antiestrogenic compounds such as tamoxifen (Tx). Various specific ligands of AEBS derived from benzylphenoxy ethanamine and a new benzoyl structure were synthesized either by modification of the aminoether side chain or by halogen substitution at the meta-, ortho-, and para position on the benzoyl group. Using the MCF-7 cellular strain and its RTx6 variant (a clone selected for its antigrowth resistance to tamoxifen), it was shown that under high drug concentrations the cytotoxicity of the ligands was directly correlated with their affinity for AEBS. In agreement with previous observations made on triphenylethylenic ligands, modification of the basic ethanamine side chain modulated the ligand affinities. Chloride in meta increased ligand efficacy, whereas chloride substitution in ortho and para decreased it. Effects on AEBS-positive MCF-7 cells were drug concentration- and time-dependent, whereas they were unspecific on the AEBS-negative RTx6 cell line. These cytotoxic effects were confirmed in the absence of estrogen receptor on human AEBS-positive uterine cervix cell carcinoma HeLa cells, but were non-specific on rat fibroblastic AEBS-negative (low concentration) NRK cells. The cytotoxicities of these ligands are related to their affinities for AEBS. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:657 / 661
页数:5
相关论文
共 27 条
[1]  
ABE O, 1992, LANCET, V339, P71
[2]   TAMOXIFEN INHIBITION OF PROLACTIN ACTION IN THE MOUSE MAMMARY-GLAND [J].
BISWAS, R ;
VONDERHAAR, BK .
ENDOCRINOLOGY, 1991, 128 (01) :532-538
[3]   EVALUATION OF ESTROGEN-RECEPTOR, ANTIESTROGEN BINDING-SITES AND CALMODULIN FOR ANTIESTROGEN RESISTANCE OF 2 CLONES DERIVED FROM THE MCF-7 BREAST-CANCER CELL-LINE [J].
BORRAS, M ;
JIN, L ;
BOUHOUTE, A ;
LEGROS, N ;
LECLERCQ, G .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (11) :2015-2024
[4]   A DIPHENYLMETHANE DERIVATIVE SELECTIVE FOR THE ANTI-ESTROGEN BINDING-SITE MAY HELP DEFINE ITS BIOLOGICAL ROLE [J].
BRANDES, LJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 124 (01) :244-249
[5]   A DIPHENYLMETHANE DERIVATIVE SPECIFIC FOR THE ANTIESTROGEN BINDING-SITE FOUND IN RAT-LIVER MICROSOMES [J].
BRANDES, LJ ;
HERMONAT, MW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 123 (02) :724-728
[6]   NEW EVIDENCE THAT THE ANTIESTROGEN BINDING-SITE MAY BE A NOVEL GROWTH-PROMOTING HISTAMINE-RECEPTOR (QUESTIONABLE-H-3) WHICH MEDIATES THE ANTIESTROGENIC AND ANTIPROLIFERATIVE EFFECTS OF TAMOXIFEN [J].
BRANDES, LJ ;
BOGDANOVIC, RP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 134 (02) :601-608
[7]   PEROXIDASE ACTIVATION OF TAMOXIFEN AND TOREMIFENE RESULTING IN DNA-DAMAGE AND COVALENTLY BOUND PROTEIN ADDUCTS [J].
DAVIES, AM ;
MARTIN, EA ;
JONES, RM ;
LIM, CK ;
SMITH, LL ;
WHITE, INH .
CARCINOGENESIS, 1995, 16 (03) :539-545
[8]   SOLUBILIZATION OF A TAMOXIFEN-BINDING PROTEIN - ASSESSMENT OF ITS MOLECULAR MASS [J].
FARGIN, A ;
FAYE, JC ;
LEMAIRE, M ;
BAYARD, F ;
POTIER, M ;
BEAUREGARD, G .
BIOCHEMICAL JOURNAL, 1988, 256 (01) :229-236
[9]  
FAYE JC, 1983, P NATL ACAD SCI-BIOL, V80, P3158, DOI 10.1073/pnas.80.11.3158
[10]   ANTI-ESTROGEN SPECIFIC, HIGH-AFFINITY SATURABLE BINDING-SITES IN RAT UTERINE CYTOSOL [J].
FAYE, JC ;
LASSERRE, B ;
BAYARD, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 93 (04) :1225-1231